Delaware
|
001-36003
|
20-3183915
|
||
(State or Other Jurisdiction
of Incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
||
4365 Executive Dr., Suite 200
San Diego, CA
|
92121
|
|||
(Address of Principal Executive Offices)
|
(Zip Code)
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02
|
Results of Operations and Financial Condition.
|
Item 9.01.
|
Financial Statements and Exhibits.
|
(d)
|
Exhibits
|
Exhibit No.
|
|
Description
|
99.1
|
|
Press release issued on May 13, 2014
|
Date: May 13, 2014
|
CONATUS PHARMACEUTICALS INC.
|
|||
By:
|
/s/ Charles J. Cashion
|
|||
Name:
|
Charles J. Cashion
|
|||
Title:
|
Senior Vice President, Finance,
|
|||
Chief Financial Officer and Secretary
|
Exhibit No.
|
|
Description
|
99.1
|
|
Press release issued on May 13, 2014
|